Aurobindo Pharma Limited (NSE: AUROPHARMA)

Aurobindo Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	33,935	43,963	41,625	53,735	27,637
Short-Term Investments	-	29,329	18,364	4,038	2,580	759.1
Trading Asset Securities	-	0.1	0.1	0.1	0.2	0.2
Cash & Short-Term Investments	63,264	63,264	62,327	45,663	56,315	28,396
Cash Growth	1.50%	1.50%	36.49%	-18.91%	98.32%	45.26%
Accounts Receivable	-	48,167	44,664	40,123	35,033	43,152
Other Receivables	-	5,150	5,356	3,619	4,979	4,894
Receivables	-	53,446	50,144	43,869	40,155	48,182
Inventory	-	98,082	85,112	75,539	90,266	76,999
Other Current Assets	-	27,265	17,874	16,157	11,500	10,548
Total Current Assets	-	242,056	215,457	181,227	198,235	164,125
Property, Plant & Equipment	-	142,849	124,918	106,660	93,155	81,166
Long-Term Investments	-	3,216	3,917	6,183	4,312	5,547
Goodwill	-	5,952	5,961	4,754	4,289	9,159
Other Intangible Assets	-	32,874	31,279	29,587	25,546	23,420
Long-Term Deferred Tax Assets	-	12,126	6,775	2,886	4,527	1,632
Long-Term Deferred Charges	-	1,941	1,980	1,792	1,361	78.2
Other Long-Term Assets	-	9,643	8,558	6,065	7,042	4,091
Total Assets	-	450,715	398,900	339,217	338,540	289,277
Accounts Payable	-	44,542	38,713	27,031	27,947	25,761
Accrued Expenses	-	17,924	16,378	12,165	14,918	19,607
Short-Term Debt	-	41,685	42,304	21,178	48,038	54,223
Current Portion of Long-Term Debt	-	117.8	121.3	57.3	-	1,397
Current Portion of Leases	-	798.8	1,032	1,599	1,006	1,110
Current Income Taxes Payable	-	2,490	2,116	580.3	2,104	950.8
Current Unearned Revenue	-	2,703	3,889	5,679	110.3	10.1
Other Current Liabilities	-	11,731	10,385	13,272	12,528	10,788
Total Current Liabilities	-	121,991	114,938	81,560	106,651	113,846
Long-Term Debt	-	21,349	6,190	2,492	1,685	-
Long-Term Leases	-	2,525	3,215	3,186	2,662	2,644
Long-Term Unearned Revenue	-	363.5	-	-	-	-
Long-Term Deferred Tax Liabilities	-	3,566	3,896	4,110	5,746	2,917
Other Long-Term Liabilities	-	1,665	1,491	1,524	2,052	900
Total Liabilities	-	152,207	130,381	93,477	119,250	121,029
Common Stock	-	585.9	585.9	585.9	585.9	585.9
Additional Paid-In Capital	-	4,179	4,179	4,179	4,179	4,179
Retained Earnings	-	276,146	247,236	233,322	209,499	158,556
Comprensive Income & Other	-	17,517	16,398	7,674	5,035	4,926
Total Common Equity	298,428	298,428	268,399	245,760	219,299	168,247
Minority Interest	-	80	120	-19.3	-8.8	1.4
Shareholders' Equity	298,508	298,508	268,519	245,741	219,290	168,248
Total Liabilities & Equity	-	450,715	398,900	339,217	338,540	289,277
Total Debt	66,476	66,476	52,862	28,513	53,391	59,374
Net Cash (Debt)	-3,213	-3,213	9,465	17,150	2,924	-30,977
Net Cash Growth	-	-	-44.81%	486.55%	-	-
Net Cash Per Share	-5.48	-5.48	16.15	29.27	4.99	-52.87
Filing Date Shares Outstanding	585.86	585.94	585.94	585.94	585.94	585.94
Total Common Shares Outstanding	585.86	585.94	585.94	585.94	585.94	585.94
Working Capital	-	120,065	100,519	99,667	91,585	50,279
Book Value Per Share	509.32	509.32	458.07	419.43	374.27	287.14
Tangible Book Value	259,602	259,602	231,159	211,419	189,464	135,667
Tangible Book Value Per Share	443.05	443.05	394.51	360.82	323.35	231.54
Land	-	8,686	8,303	6,518	2,860	2,534
Buildings	-	46,978	32,564	25,645	24,177	22,756
Machinery	-	119,040	88,308	76,809	67,543	59,187
Construction In Progress	-	27,394	44,964	29,376	24,289	16,218

Source: S&P Capital IQ. Standard template. Financial Sources.